Chinese General Practice ›› 2022, Vol. 25 ›› Issue (05): 631-635.DOI: 10.12114/j.issn.1007-9572.2021.01.015
• Cutting Edge • Previous Articles Next Articles
Latest Research Development in Histone Acetylation in the Pathogenesis of Asthma
1.Department of Respiratory and Critical Care Medicine,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524001,China
2. Laboratory of Laboratory Animal and Comparative Medicine,Guangdong Medical University,Zhanjiang 524023,China
*Corresponding author:LAI Tianwen,Doctoral supervisor;E-mail:laitianwen2011@163.com
Received:
2021-04-15
Revised:
2021-07-19
Published:
2022-02-15
Online:
2022-01-29
通讯作者:
赖天文
基金资助:
CLC Number:
CHEN Shaopeng, ZENG Minjuan, LAI Tianwen.
Latest Research Development in Histone Acetylation in the Pathogenesis of Asthma [J]. Chinese General Practice, 2022, 25(05): 631-635.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.015
[1] | CHUNG S, LEE Y G, KARPURAPU M,et al. Depletion of microRNA-451 in response to allergen exposure accentuates asthmatic inflammation by regulating Sirtuin2[J]. Am J Physiol Lung Cell Mol Physiol,2020,318(5):L921-930. DOI:10.1152/ajplung.00457.2019. |
[2] | XIA M L, XU H, DAI W,et al. The role of HDAC2 in cigarette smoke-induced airway inflammation in a murine model of asthma and the effect of intervention with roxithromycin[J]. J Asthma,2018,55(4):337-344. DOI:10.1080/02770903.2017.1337788. |
[3] | ZHOU J, GENG F H, XU J M,et al. PM2.5 exposure and cold stress exacerbates asthma in mice by increasing histone acetylation in IL-4 gene promoter in CD4+ T cells[J]. Toxicol Lett,2019,316:147-153. DOI:10.1016/j.toxlet.2019.09.011. |
[4] | MA L Y, BIAN X, LIN W C. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer[J]. J Exp Clin Cancer Res,2020,39(1):219. DOI:10.1186/s13046-020-01728-2. |
[5] | CHENG Q, SHANG Y X, HUANG W J,et al. p300 mediates the histone acetylation of ORMDL3 to affect airway inflammation and remodeling in asthma[J]. Int Immunopharmacol,2019,76:105885. DOI:10.1016/j.intimp.2019.105885. |
[6] | TANG L L, CHEN Q G, MENG Z Y,et al. Suppression of sirtuin-1 increases IL-6 expression by activation of the Akt pathway during allergic asthma[J]. Cell Physiol Biochem,2017,43(5):1950-1960. DOI:10.1159/000484119. |
[7] | STYLIANOU E. Epigenetics of chronic inflammatory diseases[J].J Inflamm Res,2019,12:1-14. DOI:10.2147/JIR.S129027. |
[8] | HE J, QIN M, CHEN Y Y,et al. Epigenetic regulation of matrix metalloproteinases in inflammatory diseases:a narrative review[J]. Cell Biosci,2020,10:86. DOI:10.1186/s13578-020-00451-x. |
[9] | KOOPMANS T, EILERS R, MENZEN M,et al. Β-catenin directs nuclear factor-κB p65 output via CREB-binding protein/p300 in human airway smooth muscle[J]. Front Immunol,2017,8:1086. DOI:10.3389/fimmu.2017.01086. |
[10] | HUANG Z W, LIEN G S, LIN C H,et al. p300 and C/EBPβ-regulated IKKβ expression are involved in thrombin-induced IL-8/CXCL8 expression in human lung epithelial cells[J]. Pharmacol Res,2017,121:33-41. DOI:10.1016/j.phrs.2017.04.020. |
[11] | CUI Z L, GU W, DING T,et al. Histone modifications of Notch1 promoter affect lung CD4+T cell differentiation in asthmatic rats[J]. Int J Immunopathol Pharmacol,2013,26(2):371-381. DOI:10.1177/039463201302600210. |
[12] | XIAO X, FAN Y H, LI J H,et al. Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation[J]. J Exp Med,2018,215(2):559-574. DOI:10.1084/jem.20170928. |
[13] | MALLESKE D T, HAYES D Jr, LALLIER S W,et al. Regulation of human airway epithelial tissue stem cell differentiation by β-catenin,P300,and CBP[J]. Stem Cells,2018,36(12):1905-1916. DOI:10.1002/stem.2906. |
[14] | SU X M, REN Y, LI M L,et al. Performance evaluation of histone deacetylases in lungs of mice exposed to ovalbumin aerosols[J]. J Physiol Pharmacol,2018,69(2). DOI:10.26402/jpp.2018.2.12. |
[15] | LI M L, SU X M, REN Y,et al. HDAC8 inhibitor attenuates airway responses to antigen stimulus through synchronously suppressing galectin-3 expression and reducing macrophage-2 polarization[J]. Respir Res,2020,21(1):62. DOI:10.1186/s12931-020-1322-5. |
[16] | HIRAI K, SHIRAI T, RACHI Y,et al. Impact of gene expression associated with glucocorticoid-induced transcript 1 (GLCCI1) on severe asthma and future exacerbation[J]. Biol Pharm Bull,2019,42(10):1746-1752. DOI:10.1248/bpb.b19-00476. |
[17] | LAI T W, WU M D, ZHANG C,et al. HDAC2 attenuates airway inflammation by suppressing IL-17A production in HDM-challenged mice[J]. Am J Physiol Lung Cell Mol Physiol,2019,316(1):L269-279. DOI:10.1152/ajplung.00143.2018. |
[18] | SAKURAI H, MORISHIMA Y, ISHII Y,et al. Sulforaphane ameliorates steroid insensitivity through an Nrf2-dependent pathway in cigarette smoke-exposed asthmatic mice[J]. Free Radic Biol Med,2018,129:473-485. DOI:10.1016/j.freeradbiomed.2018.10.400. |
[19] | BARNES P J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol,2013,131(3):636-645. DOI:10.1016/j.jaci.2012.12.1564. |
[20] | FERRARO M, GJOMARKAJ M, SIENA L,et al. Formoterol and fluticasone propionate combination improves histone deacetylation and anti-inflammatory activities in bronchial epithelial cells exposed to cigarette smoke[J]. Biochim Biophys Acta Mol Basis Dis,2017,1863(7):1718-1727. DOI:10.1016/j.bbadis.2017.05.003. |
[21] | ZHANG H P, WANG L, FU J J,et al. Association between histone hyperacetylation status in memory T lymphocytes and allergen-induced eosinophilic airway inflammation[J]. Respirology,2016,21(5):850-857. DOI:10.1111/resp.12774. |
[22] | PAN Y L, LIU L, LI S J,et al. Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms[J]. Sci Rep,2018,8(1):3624. DOI:10.1038/s41598-018-21812-0. |
[23] | LU Y, LI Z J, XIE B Q,et al. Hsa-miR-20a-5p attenuates allergic inflammation in HMC-1 cells by targeting HDAC4[J]. Mol Immunol,2019,107:84-90. DOI:10.1016/j.molimm.2019.01.010. |
[24] | HOU X X, WAN H Y, AI X Y,et al. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma[J]. Clin Respir J,2016,10(3):371-379. DOI:10.1111/crj.12227. |
[25] | MA K, LU N, ZOU F,et al. Sirtuins as novel targets in the pathogenesis of airway inflammation in bronchial asthma[J]. Eur J Pharmacol,2019,865:172670. DOI:10.1016/j.ejphar.2019.172670. |
[26] | LEE Y G, READER B F, HERMAN D,et al. Sirtuin 2 enhances allergic asthmatic inflammation[J]. JCI Insight,2019,4(4):124710. DOI:10.1172/jci.insight.124710. |
[27] | FANG P, XUE Y, ZHANG Y H,et al. SIRT7 regulates the TGF-β1-induced proliferation and migration of mouse airway smooth muscle cells by modulating the expression of TGF-β receptor I[J]. Biomedecine Pharmacother,2018,104:781-787. DOI:10.1016/j.biopha.2018.05.060. |
[28] | JANG H Y, GU S N, LEE S M,et al. Overexpression of sirtuin 6 suppresses allergic airway inflammation through deacetylation of GATA3[J]. J Allergy Clin Immunol,2016,138(5):1452-1455.e13. DOI:10.1016/j.jaci.2016.05.019. |
[29] | LIU F, SHANG Y X. Sirtuin 6 attenuates epithelial-mesenchymal transition by suppressing the TGF-β1/Smad3 pathway and c-Jun in asthma models[J]. Int Immunopharmacol,2020,82:106333. DOI:10.1016/j.intimp.2020.106333. |
[30] | ZHANG Y Z, WU Q J, YANG X,et al. Effects of SIRT1/Akt pathway on chronic inflammatory response and lung function in patients with asthma[J]. Eur Rev Med Pharmacol Sci,2019,23(11):4948-4953. DOI:10.26355/eurrev_201906_18085. |
[31] | ZHANG H, SUN Y C, RONG W,et al. miR-221 participates in the airway epithelial cells injury in asthma via targeting SIRT1[J]. Exp Lung Res,2018,44(6):272-279. DOI:10.1080/01902148.2018.1533051. |
[32] | TIEN C P, CHEN C H, LIN W Y,et al. Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation:molecular mechanism of microenvironment associated with COPD[J]. Aging (Albany NY),2019,11(13):4654-4671. DOI:10.18632/aging.102077. |
[33] | TOKI S, GOLENIEWSKA K, REISS S,et al. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation[J]. Thorax,2016,71(7):633-645. DOI:10.1136/thoraxjnl-2015-207728. |
[34] | REN Y, SU X M, KONG L F,et al. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model[J]. Inflamm Res,2016,65(12):995-1008. DOI:10.1007/s00011-016-0984-4. |
[35] | THIO C L, CHI P Y, LAI A C,et al. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate[J]. J Allergy Clin Immunol,2018,142(6):1867-1883.e12. DOI:10.1016/j.jaci.2018.02.032. |
[36] | CAO F Y, DE WEERD S, CHEN D,et al. Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)[J]. Eur J Med Chem,2020,208:112800. DOI:10.1016/j.ejmech.2020.112800. |
[37] | KIM R Y, HORVAT J C, PINKERTON J W,et al. MicroRNA-21 drives severe,steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2[J]. J Allergy Clin Immunol,2017,139(2):519-532. DOI:10.1016/j.jaci.2016.04.038. |
[38] | BI J, MIN Z H, YUAN H L,et al. PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma[J]. Clin Transl Med,2020,9(1):22. DOI:10.1186/s40169-020-0262-5. |
[39] | ITO K, LIM S, CARAMORI G,et al. A molecular mechanism of action of theophylline:Induction of histone deacetylase activity to decrease inflammatory gene expression[J]. Proc Natl Acad Sci USA,2002,99(13):8921-8926. DOI:10.1073/pnas.132556899. |
[40] | LIAO W P, TAN W S, WONG W S. Andrographolide restores steroid sensitivity to block lipopolysaccharide/IFN-γ-induced IL-27 and airway hyperresponsiveness in mice[J]. J Immunol,2016,196(11):4706-4712. DOI:10.4049/jimmunol.1502114. |
[41] | BRITT R D Jr, THOMPSON M A, FREEMAN M R,et al. Vitamin D reduces inflammation-induced contractility and remodeling of asthmatic human airway smooth muscle[J]. Ann Am Thorac Soc,2016,13():S97-98. DOI:10.1513/AnnalsATS.201508-540MG. |
[1] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[2] | WANG Xu, WEI Xu, ZHU Liguo, FENG Tianxiao, WANG Zhipeng, SHI Bin. Research Ideas of the Efficacy Mechanism and Prospect Analysis of Traditional Chinese Manipulative Therapy on Treating Spinal Degenerative Diseases with Combination of Medicine and Industry [J]. Chinese General Practice, 2023, 26(33): 4118-4124. |
[3] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[4] | ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117. |
[5] | MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102. |
[6] | WANG Jiaxin, ZHAO Yali. Domestic and International Assessment Tools for Medical Teamwork: a Systematic Review [J]. Chinese General Practice, 2023, 26(31): 3951-3962. |
[7] | WEI Mengyu, WANG Jiajia, ZHANG Yingying, LI Chunyang, LI Jiansheng. Research Status of Patient-reported Outcome Assessment Tools for Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3725-3733. |
[8] | YUAN Xiwei, NAN Yuemin. Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases [J]. Chinese General Practice, 2023, 26(30): 3841-3846. |
[9] | XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840. |
[10] | LIU Yu, YUE Ting, YANG Dongyu, ZHAO Zhongting, YANG Jibo, ZHU Tiantian. Research Progress on Mechanism of Autophagy in the Pathogenesis of Rheumatoid Arthritis [J]. Chinese General Practice, 2023, 26(29): 3710-3714. |
[11] | PU Yu, ZHANG Jixiang, DONG Weiguo. Advances in Ferroptosis and Inflammatory Bowel Disease [J]. Chinese General Practice, 2023, 26(29): 3698-3703. |
[12] | REN Yanfeng, LIU Shimeng, TAO Ying, CHEN Yingyao. A Systematic Review of Medication Preferences for Patients with Depression Based on Discrete Choice Experiment and Best-worst Scaling [J]. Chinese General Practice, 2023, 26(28): 3559-3564. |
[13] | TANG Shilan, XIE Kexin, LIU Lingyu, QI Tiantian, YANG Yansui. Advances in Rehabilitation Outcomes and Care in Patients with Prolonged Disorders of Consciousness [J]. Chinese General Practice, 2023, 26(27): 3342-3348. |
[14] | LIANG Xuemei, WANG Rui, ZHAO Yuhuan, XU Tianjiao, WANG Wei, SUN Weidong. Transcranial Low-level Laser Therapy: a Novel Treatment for Depression [J]. Chinese General Practice, 2023, 26(27): 3335-3341. |
[15] | CHEN Xiaofen, CHEN Yuhan, MA Juan. Recent Strides in Novel Treatments for Inflammatory Bowel Disease [J]. Chinese General Practice, 2023, 26(27): 3349-3354. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||